Hypoxia upregulates Cxcl12 in hepatocytes by a complex mechanism involving hypoxia-inducible factors and transforming growth factor-β

• Published in: Cytokine (Philadelphia, Pa.) Pa.), 2020-03, Vol.127, p.154986-154986, Article 154986
• Main Authors: Strickland, Jenna, Garrison, Domonique, Copple, Bryan L.
• Format: Article
• Language: English
• Subjects: Cxcl12; Fibrosis; Hepatocytes; Hypoxia; Liver; TGF-β
• ISSN: 1043-4666; 1096-0023
• DOI: 10.1016/j.cyto.2020.154986

Hypoxia activates HIF-1a and/or HIF-2a in hepatocytes which stimulates their translocation to the nucleus. In the nucleus, they heterodimerize with HIF-1b (not shown) which increases expression of a yet to be identified mediator (indicated by a question mark in the diagram) that is secreted and converts latent TGF-b to active TGF-b. TGF-b then activates its receptor which stimulates upregulation of Cxcl12. [Display omitted] •The mechanism by which Cxcl12 is upregulated in the liver is poorly understood.•Hypoxia stimulates upregulation of Cxcl12 in a HIF-1α- and HIF-2α-dependent manner.•TGF-β is also required for upregulation of Cxcl12 in hypoxic hepatocytes. Cxcl12, or stromal-derived factor-1, is a chemokine produced by several hepatic cell types, including hepatocytes, after liver injury and surgical resection. Studies have revealed that Cxcl12 is important for regeneration of the liver after surgical resection and for development of liver fibrosis during chronic liver injury. While the function of Cxcl12 in the liver is well established, the mechanism by which Cxcl12 is upregulated is not fully understood. Because regions of hypoxia develop in the liver following injury, we tested the hypothesis that hypoxia upregulates Cxcl12 in hepatocytes by a hypoxia-inducible factor (HIF)-dependent mechanism. To test this hypothesis, primary mouse hepatocytes were isolated from the livers of HIF-1α-deficient mice or HIF-1β-deficient mice and exposed to 1% oxygen. Cxcl12 expression was increased following exposure of primary mouse hepatocytes to 1% oxygen. Previously we have shown, that in addition to HIFs, transforming growth factor-β is required for upregulation of a subset of genes in hypoxic hepatocytes. To examine the role of TGF-β in regulation of Cxcl12 during hypoxia, hepatocytes were pretreated with the TGF-β receptor I inhibitor, SB431542. Upregulation of Cxcl12 by hypoxia was partially prevented in hepatocytes from HIF-1α-deficient mice and completely prevented in hepatocytes from HIF-1β-deficient hepatocytes. This suggests that under hypoxic conditions, both HIF-1α and HIF-2α regulate Cxcl12 in hepatocytes. Pretreatment of hepatocytes with SB431542 completely prevented upregulation Cxcl12 by hypoxia. Further, treatment of hepatocytes with recombinant TGF-β1 upregulated Cxcl12 in hepatocytes cultured in room air. Collectively, these studies demonstrate that hypoxia upregulates Cxcl12 in primary mouse hepatocytes by a mechanism that involves HIFs and TGF-β